• HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • Articles
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your event to ACNR
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR funded?
    • Editorial Board
    • Peer Reviewers
    • Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Mail Signup
    • ACNR Privacy Policy
This website is intended for healthcare professionals
ACNR
  • HOME
  • ISSUES
  • EXPLORE CONTENT
    • Introduction
    • From the Editor
    • Articles
      • View All
      • Peer Reviewed
      • Personal Perspectives
      • History
    • Book Reviews
    • Case Reports
    • News
    • Sponsored Editorial
  • EVENTS
    • Introduction
    • Event News
    • Conference Reports
    • Submit your Course or Conference
  • AUTHORS
    • Introduction
    • ACNR Author Guidelines
    • Author Disclosure
  • RESOURCES
  • ABOUT
    • Introduction
    • How is ACNR Funded?
    • Editorial Board
    • Peer Reviewers
    • ACNR Policies and Forms
    • Ethics and Malpractice
    • Email Newsletter
    • Journal Signup
    • ACNR Privacy Policy
  • Menu

European research study aims to improve treatment for traumatic brain injury

Posted on 8 January, 2018 - Industry News, Neurology News

News from ICON plc

VERITON PHARMA LTD New company name for Special Products Ltd

Posted on 8 January, 2018 - Industry News, Neurology News

News from Veriton Pharma

Specialist Neurological Rehabilitation Service in Lincoln rated Outstanding by the CQC

Posted on 8 January, 2018 - Industry News

News from The Christchurch Group

Epistatus® 10mg oromucosal solution Midazolam now available to prescribe

Posted on 8 January, 2018 - Industry News, Neurology News

News from Veriton Pharma

Applied EEG Neuroscience specialists BrainTrainUK launches new QEEG service

Posted on 8 January, 2018 - Industry News, Neurology News

News from BrainTrainUK

Neurological Advocacy Service is two years’ old

Posted on 8 December, 2017 - Neurology News

Neurology Advocacy Service

Society for Neuro-Oncology Meeting

Posted on 5 December, 2017 - Online First

News from the Society for Neuro-Oncology meeting

Are there limitations of headache days used alone as a diagnostic tool?

Posted on 4 December, 2017 - Industry News, Online First

Enrico Greppi Award at EHF Congress for study supported and funded by Allergan

Novartis data shows treatment with erenumab (AMG 334) cuts migraine days by half

Posted on 4 December, 2017 - Industry News, Online First

Migraine news from Novartis – Phase III STRIVE study shows positive results

  • «
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • »

Recent News

  • Tavapadon: A game-changing partial dopamine agonist?
  • New mechanism for blood flow regulation in the brain
  • Sleep apnoea linked to changes in the brain
  • Genetic testing for neurodevelopmental conditions
  • ‘Digital twin’ brain tech for people with Parkinson’s given funding
  • Accelerated Approval in Huntington’s disease?
  • Vamorolone for Duchenne Muscular Dystrophy
  • Episodic migraine in children and adolescents
  • A link between gut bacteria and Alzheimer’s disease?
  • Cognitive impairment in HD

Categories

  • ACNR News (8)
  • Acquired Brain Injury (14)
  • Alzheimer's Disease (26)
  • Amyotrophic Lateral Sclerosis (ALS) (7)
  • Artificial Intelligence (6)
  • Association of British Neurologists Trainees (4)
  • Australia/New Zealand (1)
  • Awards & Appointments (10)
  • Book Reviews (2)
  • Brain Mapping (2)
  • Brain tumours (3)
  • Case Reports (15)
  • Charcot-Marie-Tooth Disease (1)
  • Charity (5)
  • Cognition (2)
  • Comment (2)
  • Course & Conference Previews (11)
  • Courses & Conferences (1)
  • COVID-19 Articles (4)
  • Dementia (11)
  • Digital Health (2)
  • Epilepsy (16)
  • Essay (1)
  • Genetics (1)
  • Headache (17)
  • Hereditary Spastic Paraplegia (1)
  • Huntington's disease (4)
  • Industry News (178)
  • Journal Reviews (1)
  • Major Depressive Disorder (3)
  • Management Topics in Epilepsy (1)
  • Movement Disorders (14)
  • Multiple Sclerosis (27)
  • Myasthenia Gravis (7)
  • Neurodegenerative diseases (1)
  • Neurodevelopmental disorders (4)
  • Neuroimmunology (2)
  • Neurological Literature (2)
  • Neurology News (37)
  • Neuromuscular (1)
  • Neuropsychiatry (2)
  • Neurosurgery (1)
  • NHS News (2)
  • Online First (14)
  • Pain (4)
  • Parkinson’s Disease (28)
  • Rehabilitation (10)
  • Rehabilitation Articles (4)
  • Research (6)
  • Sleep (3)
  • Sleep Series (4)
  • Special Feature (6)
  • Sponsored Feature (7)
  • Stroke (10)
  • Stroke Series (3)
  • Syncope (1)
  • Uncategorised (45)
  • Uncategorized (1)
  • Published by Whitehouse Publishing
  • The Lynch, Mere, Wiltshire BA12 6DQ, United Kingdom
  • info@acnr.co.uk
  • +44 1747 860168

FOLLOW US

  • Facebook
  • Instagram
  • X
  • Linkedin

RSS FEEDS

  • ACNR RSS
  • All
  • Articles
  • Events

ACNR SIGNUPS

Join our email list to be notified when there is new content or upcoming events. For UK-based specialists join our journal mailing list.

© 2024 ACNR. Published by Whitehouse Publishing. Read our Privacy and Cookie Policy. Website by Sugar Web.

SIGN UP FOR OUR EMAILING LIST

Sign up to receive our email newsletter with links to the latest content. ACNR is free, thanks to the support of advertisers. The editorial content is peer reviewed and remains completely independent unless clearly specified.

For UK-based specialists, sign up for our journal mailing list.

WARNING

URL here

You are now leaving the ACNR website, please click the "Continue" button below. If you do not wish to leave, please close this pop-up.

Continue